long-acting β2-agonists (LABA)

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

AsthmaPulmonary Disease, Chronic Obstructive

Unknown Phase

Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan

CompletedNCT05402020

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2022-09-30End: 2023-02-13Updated: 2024-08-09

Exacerbation Risk in Asthma

CompletedNCT05501639

Boehringer IngelheimAsthma

Start: 2021-05-14End: 2021-11-02Updated: 2024-04-01